End-of-day quote
Korea S.E.
03:30:00 20/05/2024 am IST
|
5-day change
|
1st Jan Change
|
14,220
KRW
|
+2.01%
|
|
+20.71%
|
+34.79%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
71,577
|
79,626
|
3,09,325
|
2,49,696
|
2,12,385
|
2,33,123
|
Enterprise Value (EV)
1 |
61,535
|
85,731
|
2,84,800
|
2,35,379
|
1,83,323
|
2,10,837
|
P/E ratio
|
-5.89
x
|
-14.8
x
|
-9.87
x
|
-72.3
x
|
-13.1
x
|
-34.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
12.7
x
|
9.75
x
|
28.1
x
|
21.1
x
|
16.9
x
|
16.7
x
|
EV / Revenue
|
10.9
x
|
10.5
x
|
25.9
x
|
19.9
x
|
14.6
x
|
15.1
x
|
EV / EBITDA
|
-12
x
|
-42.3
x
|
-340
x
|
-70.9
x
|
-22
x
|
-76.6
x
|
EV / FCF
|
41.2
x
|
-7.33
x
|
-68.2
x
|
-10.6
x
|
-25
x
|
-29.2
x
|
FCF Yield
|
2.43%
|
-13.6%
|
-1.47%
|
-9.42%
|
-4.01%
|
-3.43%
|
Price to Book
|
4.35
x
|
7.13
x
|
7.32
x
|
4.74
x
|
3.03
x
|
3.66
x
|
Nbr of stocks (in thousands)
|
8,969
|
8,969
|
16,447
|
17,738
|
22,100
|
22,097
|
Reference price
2 |
7,981
|
8,878
|
18,808
|
14,077
|
9,610
|
10,550
|
Announcement Date
|
15/03/19
|
11/03/20
|
19/03/21
|
18/03/22
|
20/03/23
|
13/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,635
|
8,167
|
11,013
|
11,818
|
12,574
|
13,968
|
EBITDA
1 |
-5,113
|
-2,026
|
-837.1
|
-3,322
|
-8,323
|
-2,752
|
EBIT
1 |
-7,286
|
-5,367
|
-4,921
|
-7,894
|
-12,932
|
-8,408
|
Operating Margin
|
-129.29%
|
-65.72%
|
-44.68%
|
-66.8%
|
-102.85%
|
-60.19%
|
Earnings before Tax (EBT)
1 |
-12,080
|
-5,490
|
-23,194
|
-3,464
|
-14,007
|
-6,701
|
Net income
1 |
-11,969
|
-5,368
|
-23,101
|
-3,420
|
-13,959
|
-6,709
|
Net margin
|
-212.38%
|
-65.73%
|
-209.76%
|
-28.93%
|
-111.02%
|
-48.03%
|
EPS
2 |
-1,354
|
-598.5
|
-1,906
|
-194.6
|
-732.0
|
-304.0
|
Free Cash Flow
1 |
1,492
|
-11,701
|
-4,179
|
-22,182
|
-7,347
|
-7,231
|
FCF margin
|
26.48%
|
-143.28%
|
-37.94%
|
-187.69%
|
-58.43%
|
-51.77%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/03/19
|
11/03/20
|
19/03/21
|
18/03/22
|
20/03/23
|
13/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
6,105
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
10,042
|
-
|
24,525
|
14,318
|
29,062
|
22,286
|
Leverage (Debt/EBITDA)
|
-
|
-3.013
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,492
|
-11,701
|
-4,179
|
-22,182
|
-7,347
|
-7,231
|
ROE (net income / shareholders' equity)
|
-54.8%
|
-38.7%
|
-84.2%
|
-7.18%
|
-22.7%
|
-10%
|
ROA (Net income/ Total Assets)
|
-9.1%
|
-5.27%
|
-4.22%
|
-6.18%
|
-9.75%
|
-6.51%
|
Assets
1 |
1,31,479
|
1,01,831
|
5,47,096
|
55,305
|
1,43,227
|
1,03,126
|
Book Value Per Share
2 |
1,835
|
1,245
|
2,570
|
2,972
|
3,174
|
2,886
|
Cash Flow per Share
2 |
697.0
|
285.0
|
228.0
|
199.0
|
144.0
|
390.0
|
Capex
1 |
8,342
|
6,933
|
3,438
|
8,391
|
2,987
|
3,569
|
Capex / Sales
|
148.02%
|
84.9%
|
31.21%
|
71%
|
23.76%
|
25.55%
|
Announcement Date
|
15/03/19
|
11/03/20
|
19/03/21
|
18/03/22
|
20/03/23
|
13/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +34.79% | 231M | | -6.01% | 12.23B | | -3.86% | 8.17B | | +33.66% | 5.74B | | -7.35% | 4.24B | | -55.63% | 2.97B | | +13.62% | 2.73B | | -3.85% | 2.38B | | +30.67% | 2.26B | | -4.31% | 1.87B |
Diagnostic & Testing Substances
|